Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Teriflunomide Tablets

Approval Number

国药准字HJ20180038

CompanySanofi-Aventis U.S. Llc

Registration Date

June 7, 2023

Previous Approval Numbers

H20180038

Drug Information

Generic Name

特立氟胺片

Trade Name

奥巴捷

Dosage Form

片剂

Strength

7mg

Drug Type

化学药品

Registration Date

June 7, 2023

Expiry Date

June 6, 2028

Company Information

Applicant Company

Company NameSanofi-Aventis U.S. Llc

Company Address

55 Corporate Drive, Bridgewater, NJ 08807 United States of America

Manufacturing Company

Company NameOPELLA HEALTHCARE INTERNATIONAL SAS

Company Address

56, Route de Choisy, 60200 Compiègne, France

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy